ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Co-stimulation"

  • 2019 American Transplant Congress

    Costimulation Blockade Modulates Humoral Responses in Highly Sensitized Transplant Recipients

    J. Kwun, B. Ezekian, P. Schroder, M. Manook, J. Yoon, M. Mulvihill, K. Freischlag, J. Yi, S. Knechtle

    Surgery, Duke Transplant Center, Durham, NC

    *Purpose: Broad human leukocyte antigen sensitization is a significant barrier to successful solid organ transplantation. Sensitized patients have poor access to donor organs, high wait…
  • 2019 American Transplant Congress

    FcγRIIB is a Novel CD8+ Effector T Cell Intrinsic Regulatory Pathway That Correlates with Freedom from Rejection in Renal Transplant Patients

    A. B. Morris1, D. F. Pinelli1, D. Liu1, J. M. Boss2, C. D. Scharer2, M. Fribourg3, P. Cravedi3, P. S. Heeger3, M. L. Ford1

    1Surgery, Emory University, Atlanta, GA, 2Micro & Immuno, Emory University, Atlanta, GA, 3Center for Translational Transplant Research, Icahn SOM at Mount Sinai, New York, NY

    *Purpose: To understand the functional role and clinical relevance of FcγRIIB on CD8+ T cells in transplantation.*Methods: See results*Results: FcγRIIB is the sole inhibitory Fcγ…
  • 2019 American Transplant Congress

    IFNAR Signaling Augments Plasmacytoid Dendritic Cell Activation during Costimulation Independent Rejection

    J. Habib, D. Mathews, Y. Dong, A. Stephenson, A. Ghosh, C. Breeden, A. Adams

    Surgery, Emory University, Atlanta, GA

    *Purpose: Costimulation blockade (CoB) is a promising new transplant immunosuppression strategy offering improved long-term patient and allograft survival without the nephrotoxicity of calcineurin inhibitors. However,…
  • 2019 American Transplant Congress

    The Use of mTOR Inhibitors Prevents Acute Cellular Rejection in Kidney Transplantation on Belatacept Therapy

    J. Shoji, J. C. Leung, Q. Tang, J. P. Roberts, F. Vincenti

    University of California San Francisco, San Francisco, CA

    *Purpose: Belatacept is a costimulatory blocker that is used as de novo maintenance immunosuppression in kidney transplantation to avoid toxic effects of calcineurin inhibitors and…
  • 2019 American Transplant Congress

    Memory T Follicular Helper Cell Alloresponse is Memory B Cell Independent and Inhibited by CD28 Costimulation Blockade

    S. Zeng, G. M. La Muraglia II, M. L. Ford, I. R. Badell

    Emory University School of Medicine, Atlanta, GA

    *Purpose: Donor-directed HLA antibodies are an important cause of renal allograft injury, but reliable and durable therapeutic options to prevent or eliminate donor-specific antibodies (DSA)…
  • 2019 American Transplant Congress

    In Vivo Treg Expansion under Costimulation Blockade Targets Early Rejection and Improves Long-Term Outcome

    C. Schwarz1, B. Mahr2, L. Unger1, N. Pilat2, H. Regele3, T. Wekerle2

    1Dept. of Surg. / Div. of Transplantation, Medical University Vienna, Vienna, Austria, 2Dept. of Surg. / Section of Transplantation Immunology, Medical University Vienna, Vienna, Austria, 3Clinical Institute of Pathology, Medical University Vienna, Vienna, Austria

    *Purpose: Early rejection episodes are a major problem under CTLA4Ig/belatacept-based immunosuppression. We have previously shown that CTLA4Ig therapy is dependent on Tregs at low (LD)…
  • 2019 American Transplant Congress

    Belatacept Based Simultaneous Calcineurin Inhibitor Avoidance/Early Corticosteroid Withdrawal is Associated with Low New Onset Diabetes Risk

    A. R. Shields1, P. West-Thielke2, E. S. Woodle1, D. B. Kaufman3, J. Lipscomb4, J. P. Leone5, A. Wiseman6, E. King4, A. J. Matas7, R. R. Alloway for the BEST Study Group4

    1Transplant Surgery, U of Cincinnati, Cincinnati, OH, 2UIC, Chicago, IL, 3Transplant Surgery, U of Wisconsin, Madison, WI, 4U of Cincinnati, Cincinnati, OH, 5Tampa General, Tampa, FL, 6U of Colorado, Denver, CO, 7U Minnesota, Minneapolis, MN

    *Purpose: Calcineurin inhibitor (CNI) and/or corticosteroid (CCS) therapy are associated with significant risk of new onset diabetes after transplantation (NODAT). An important consideration for simultaneous…
  • 2019 American Transplant Congress

    CNI-Free Therapy with Iscalimab (anti-CD40 mAb) Preserves Allograft Histology Compared to Standard of Care after Kidney Transplantation

    E. Farkash1, A. Naik1, H. Tedesco-Silva2, B. Nashan3, O. Witzke4, M. van den Hoogen5, S. Berger6, D. M. Cibrik7, S. Mulgaonkar8, D. B. Leeser9, R. Alloway10, A. Patel11, J. Pratchke12, C. Sommerer13, A. Wiseman14, A. Van Zuilen15, U. Laessing16, J. Rush16, B. Haraldsson16

    1Univ of Michigan, Ann Arbor, MI, 2Hospital do Rim, São Paulo, Brazil, 3Univ. Hamburg, Hamburg, Germany, 4Univ Essen, Essen, Germany, 5Erasmus MC, Rotterdam, Netherlands, 6UMC Groningen, Gröningen, Netherlands, 7Univ of Kansas, Kansas City, KS, 8Saint Barnabas MC, Livingston, NJ, 9East Carolina Univ, Greenville, NC, 10Univ of Cincinnati, Cincinnati, OH, 11Henry Ford Hosp, Detroit, MI, 12Charité Univ, Berlin, Germany, 13Univ Heidelberg, Heidelberg, Germany, 14Univ of Colorado SM, Denver, CO, 15Univ MC, Utrecht, Netherlands, 16Novartis, Basel, Switzerland

    *Purpose: To assess if calcineurin (CNI)-free therapy with iscalimab preserves the quality of transplanted kidney grafts.*Methods: Iscalimab (CFZ533) is a new, fully human, Fc-silenced, non-depleting,…
  • 2019 American Transplant Congress

    Early T Cell Infiltration is Modulated by PD-1/PD-L1 Interactions in Kidney Graft

    Y. Shim, R. Fan, N. Dvorina, W. Baldwin

    Inflammation and Immunity, Lerner Research Institute, Cleveland, OH

    *Purpose: Allogeneic transplants elicit dynamic T cell responses that are modulated by positive and negative co-stimulatory receptors. We have investigated the impact of PD-1, a…
  • 2019 American Transplant Congress

    The mIR17-92 Cluster Promotes Costimulation Resistant Effector Memory T Cell-Mediated Alloresponses

    H. Xu1, Q. Guo1, M. Song1, A. Miler1, Q. Li2, A. Kirk1

    1Surgery, Duke University, Durham, NC, 2Immunology, Duke University, Durham, NC

    *Purpose: CD57 expression has been shown to identify a subset of memory T cells that are resistant to CD28/B7 costimulation blockade (B7CoB). This study was…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 30
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences